Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.3 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.055 | 0.3 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.3 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |